The investigators are looking to see if a certain dose of stereotactic body radiation therapy (SBRT) may be a viable treatment option for recurrent or residual pancreatic or periampullary adenocarcinoma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Late Gastrointestinal Toxicities
Timeframe: 3 months post-treatment to date of first progression or date of death, whichever comes first assessed up to 36 months